A Europe-wide strategy to enhance transplantation of highly sensitized patients on basis of Acceptable HLA mismatches

EUROSTAM is a project financed by the EC (FP7-HEALTH Collaborative project). The project started on 1 december 2012 and will last for three years.

The project adresses the FP7 workprogramme topic: Innovative approaches to solid organ transplantation.
Main aim of the project is to determine the feasibility and advantage to implement a Europe-wide acceptable mismatch program to facilitate transplantation of highly sensitized patients, who do not have a chance to be transplanted in their own population. The simulation studies on basis of the HLA phenotypes in different European populations will show the theoretical advantage of a Europe-wide acceptable mismatch program. The results of these studies will be published on the EUROSTAM website and in an international peer reviewed journal.

Our goal:

The major objective of the 10 partners in this project is to analyze the feasibility and requirements for a Europe-wide acceptable mismatch program to enhance transplantation of patients with rare HLA phenotypes in their own population. Read more ….

Consortium Meeting – Sept 2013

On September 19-20 2013, the second consortium meeting of EUROSTAM was organized by Institut D'Investigacions Biomediques August Pi I Sunyer (IDIBAPS) in Barcelona, Spain. The two day programme consisted of two meetings discussing the results and the future plans of...

read more

EU-flag_yellow_low_klein

The project has received funding from the European Union’s Seventh Framework Programme [FP7/2007-2013] under grant agreement number HEALTH-F4-2012-305385